Intelligent Medicine Acquisition Corp.
Status: Liquidated
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $207.00M |
|---|---|
| IPO Date | Nov 5, 2021 |
| CEO | Gregory C. Simon |
| Left Lead | Cantor Fitzgerald |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 15 + 7 |
| IPO Sector |
Healthcare
Life science companies that are using artificial intelligence (“AI”), machine learning (“ML”) and big data to create and power a new model of drug discovery |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Feb 8, 2023 |
| Closing Date | Apr 27, 2023 |
IQMD
IQMDU
IQMDW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Intelligent Medicine Acquisition Corp.:
- Structure and cap table
- 5 directors & officers
- 10 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Gregory C. Simon | 69 | Chief Executive Officer, Chief Financial Officer and Director |
| Jack D. Hidary | 52 | Chairman |
| Joseph L. Schocken | 74 | Director |
| Patience Marime-Ball | 52 | Director |
| Kavita Patel | 47 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Cantor Fitzgerald | BR | 18,000,000 | units |
| 18,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 2.00 | % |
Sign in to view more advisor data.
Filings
Sign in to view 10 filings.